Aktienanalyse zu Core Laboratories Inc (CLB)CLBCore Laboratories Inc

Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. It assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. Its segments include Reservoir Description, which provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry, and Production Enhancement segment, which provides integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions aimed at increasing the effectiveness of enhanced oil recovery projects. It operates in the Industrials sector (OIL & GAS FIELD SERVICES, NEC industry).

Core Laboratories Inc is currently a hold. The stock is priced at $9.91, with a forward P/E of 19.76, indicating potential overvaluation compared to its earnings growth. The RSI is at 48.22, suggesting the stock is neither overbought nor oversold, which may indicate a stable price point. However, the stock has seen a significant year-to-date decline of 41.53%, which raises concerns about its recovery potential in the near term. The main risk is the recent downgrade by BofA, which could lead to further price pressure.

18 analysts cover CLB: 10 rate it Buy, 8 Hold and 0 Sell. The average price target is 11.50.